January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product ...
January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions ...
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX FO ...
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...
January 16, 2024 — Penumbra, Inc., a thrombectomy company, has recently secured CE Mark (Conformité Européenne) for its ...
January 11, 2024 — Acute cardiovascular manifestations of COVID-19, such as heart failure, thrombosis, and dysrhythmia ...
January 9, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...
January 8, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention ...
As the Diagnostic and Interventional Cardiology (DAIC) team welcomes in the New Year, we also have taken a few moments ...
January 4, 2024 — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural ...
January 4, 2024 — The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of ...
January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care ...
December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX ...
December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...